Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006675,
umls-concept:C0007447,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0086418,
umls-concept:C0142554,
umls-concept:C0205314,
umls-concept:C0282549,
umls-concept:C0679622,
umls-concept:C1280500,
umls-concept:C1550548,
umls-concept:C1554184,
umls-concept:C1555714,
umls-concept:C1704259,
umls-concept:C1705654,
umls-concept:C1705987,
umls-concept:C1879547
|
pubmed:issue |
5
|
pubmed:dateCreated |
1996-6-6
|
pubmed:abstractText |
The effects of the receptor-mediated Ca2+ entry blocker, SK&F 96365 on thapsigargin (TSG)-induced Ca2+ entry in fura-2-loaded HL-60 cells were studied. After Ca2+ release induced by 30 nM TSG, readmission of Ca2+ resulted in a sustained Ca2+ entry, which could be partially inhibited by 1-3 microM SK&F 96365. Surprisingly, SK&F 96365 at 30-100 microM, instead of causing a stronger inhibition, actually promoted Ca2+ entry. Furthermore, at 16-100 microM, this drug released intracellular Ca2+ on its own and induced Ca2+ entry upon readmission of Ca2+. This SK&F 96365-activated Ca2+ entry pathway was insensitive to nifedipine and, interestingly, accessible to Ni2+ and La3+. However, SK&F 96365 (30 microM) almost completely blocked (basal) Mn2+ entry and only caused 4.4% of the cells to be stained with trypan blue, strongly suggesting that the SK&F 96365-activated cation entry was not due to damage nor to a very nonselective permeabilization of the plasma membrane. These data indicate that low concentrations of SK&F 96365 inhibited Ca2+ entry and higher concentrations activated a novel cation entry pathway. Because these 2 opposing effects overlapped at an intermediate concentration (16 microM), which is within the range commonly used to block Ca2+ entry, cautious use of this Ca2+ antagonist appears to be warranted.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
605-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8615896-Calcium,
pubmed-meshheading:8615896-Calcium Channel Blockers,
pubmed-meshheading:8615896-Cell Membrane,
pubmed-meshheading:8615896-Dose-Response Relationship, Drug,
pubmed-meshheading:8615896-HL-60 Cells,
pubmed-meshheading:8615896-Homeostasis,
pubmed-meshheading:8615896-Humans,
pubmed-meshheading:8615896-Imidazoles
|
pubmed:year |
1996
|
pubmed:articleTitle |
Dual effects of SK&F 96365 in human leukemic HL-60 cells. Inhibition of calcium entry and activation of a novel cation influx pathway.
|
pubmed:affiliation |
Department of Physiology, Faculty of Medicine, University of Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|